earnings
confidence high
sentiment positive
materiality 0.75
Bio-Techne Q1 FY2022 revenue $257.7M, organic growth 21%; adjusted EPS $1.83 vs $1.43
BIO-TECHNE Corp
2022-Q1 EPS reported
$1.69
revenue$257,719,000
- Q1 FY2022 revenue $257.7M, organic growth 21% (reported 26%).
- GAAP EPS $1.69, adjusted EPS $1.83 vs $1.43 prior year.
- Protein Sciences organic growth 26% (third consecutive quarter >20%).
- China revenue grew over 50% organic; North America and Europe at least 20%.
- Board declared $0.32 per share dividend payable Nov 26, 2021 to holders of record Nov 12.